Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal adipose tissue morphology (HP:0009124)help
Parent Node:
expand
Abnormality of subcutaneous fat tissue (HP:0001001)help
Parent Node:
expand
Decreased adipose tissue (HP:0040063)help
..Starting node
..expand
Reduced subcutaneous adipose tissue (HP:0003758)help
Term ID: 3758
Name: Reduced subcutaneous adipose tissue
Synonym: Decreased subcutaneous adipose tissue; Decreased subcutaneous fat; Reduced fat tissue below the skin; Reduced subcutaneous fat; Scanty adipose tissue
Definition: A reduced amount of fat tissue in the lowest layer of the integument. This feature can be appreciated by a reduced skinfold thickness.
Comments:
Reference: HP:0003758
Genes and Diseases:
 
       Child Nodes:
........expandMinimal subcutaneous fat (HP:0003717) help
................... HP:0005320 Lack of facial subcutaneous fat
........expandDecreased adipose tissue around neck (HP:0005995) help

 Sister Nodes: 
..expandAdipose tissue loss (HP:0008887) help
..expandReduced intraabdominal adipose tissue (HP:0025128) help
..expandReduced intrathoracic adipose tissue (HP:0003809) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0AGPAT2 CL E G H10555325OMIM:608594Lipodystrophy, congenital generalized, type 1.85
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0ATP6V1A CL E G H523851OMIM:617403Cutis laxa, autosomal recessive, type IID3
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0ATP6V1E1 CL E G H529857OMIM:617402Cutis laxa, autosomal recessive, type IIC.2
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0BSCL2 CL E G H2658015832OMIM:269700Lipodystrophy, congenital generalized, type 2.105
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophyHP:0040281 - Very frequent105
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0CAV1 CL E G H8571527OMIM:612526Lipodystrophy, congenital generalized, type 311
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0ERCC6 CL E G H20743438OMIM:133540Cockayne syndrome, type B.199
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0ERCC8 CL E G H11613439OMIM:216400Cockayne syndrome A.55
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0FBN1 CL E G H22003603OMIM:154700Marfan syndrome.1361
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0FH CL E G H22713700OMIM:606812Fumarase deficiency.301
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0GNB2 CL E G H27834398OMIM:619503NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0H4C5 CL E G H83674790OMIM:619950
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0IGF1R CL E G H34805465OMIM:270450Insulin-Like growth factor I, resistance to.268
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0INSR CL E G H36436091ORPHA:508LeprechaunismHP:0040281 - Very frequent229
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0INSR CL E G H36436091ORPHA:769Rabson-Mendenhall syndromeHP:0040282 - Frequent229
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0KCNK9 CL E G H513056283OMIM:612292BIRK-BAREL SYNDROME4
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0LEMD2 CL E G H22149621244OMIM:619322MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS1
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0LMNA CL E G H40006636ORPHA:280365Autosomal semi-dominant severe lipodystrophic laminopathyHP:0040281 - Very frequent645
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0LMNA CL E G H40006636OMIM:151660Lipodystrophy, familial partial, type 2.645
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0LMNA CL E G H40006636OMIM:248370Mandibuloacral dysplasia.645
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0NAA10 CL E G H826018704OMIM:300855Ogden syndrome23
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0PLIN1 CL E G H53469076ORPHA:280356PLIN1-related familial partial lipodystrophyHP:0040281 - Very frequent19
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome.138
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040281 - Very frequent138
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 3.42
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0PTF1A CL E G H25629723734OMIM:609069Pancreatic and cerebellar agenesis.22
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0RBM28 CL E G H5513121863OMIM:612079Alopecia, neurologic defects, and endocrinopathy syndrome.1
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0SKI CL E G H649710896OMIM:182212Shprintzen-Goldberg craniosynostosis syndrome150
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0SLC25A24 CL E G H2995720662OMIM:612289Fontaine progeroid syndrome
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0SLC25A24 CL E G H2995720662ORPHA:2963Progeroid syndrome, Petty typeHP:0040281 - Very frequent
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0SLC2A2 CL E G H651411006OMIM:227810Fanconi-Bickel syndrome.71
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome.7
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0TGFB1 CL E G H704011766OMIM:131300Camurati-Engelmann disease13
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0TGFB3 CL E G H704311769OMIM:615582LOEYS-DIETZ SYNDROME 5; LDS585
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0TOP3A CL E G H715611992OMIM:618097Microcephaly, growth restriction, and increased sister chromatid exchange 2.
HP:0003758HP:0003758Reduced subcutaneous adipose tissue0ZMPSTE24 CL E G H1026912877OMIM:608612Mandibuloacral dysplasia with type B lipodystrophy83
HP:0003758HP:0005995Decreased adipose tissue around neck1CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0003758HP:0003717Minimal subcutaneous fat1CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0003758HP:0003717Minimal subcutaneous fat1LMNA CL E G H40006636ORPHA:280365Autosomal semi-dominant severe lipodystrophic laminopathyHP:0040281 - Very frequent645
HP:0003758HP:0003717Minimal subcutaneous fat1NAA10 CL E G H826018704OMIM:300855Ogden syndrome.23
HP:0003758HP:0003717Minimal subcutaneous fat1SKI CL E G H649710896OMIM:182212Shprintzen-Goldberg craniosynostosis syndrome.150
HP:0003758HP:0005995Decreased adipose tissue around neck1ZMPSTE24 CL E G H1026912877OMIM:608612Mandibuloacral dysplasia with type B lipodystrophy.83
HP:0003758HP:0005320Lack of facial subcutaneous fat2CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711


Genes (30) :AGPAT2 ATP6V1A ATP6V1E1 BSCL2 CAV1 ERCC6 ERCC8 FBN1 FH GNB2 H4C5 IGF1R INSR KCNK9 LEMD2 LMNA NAA10 PLIN1 POLR3A PPARG PTF1A RBM28 SKI SLC25A24 SLC2A2 SOX18 TGFB1 TGFB3 TOP3A ZMPSTE24

Diseases (38) :OMIM:608594 OMIM:617403 OMIM:617402 OMIM:269700 ORPHA:363400 OMIM:612526 OMIM:606721 OMIM:133540 OMIM:216400 OMIM:616914 OMIM:154700 OMIM:606812 OMIM:619503 OMIM:619950 OMIM:270450 ORPHA:508 ORPHA:769 OMIM:612292 OMIM:619322 ORPHA:280365 OMIM:151660 OMIM:248370 OMIM:300855 ORPHA:280356 OMIM:264090 ORPHA:3455 OMIM:604367 OMIM:609069 OMIM:612079 OMIM:182212 OMIM:612289 ORPHA:2963 OMIM:227810 OMIM:137940 OMIM:131300 OMIM:615582 OMIM:618097 OMIM:608612
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.